Azithromycin Injection Shortage
Last Updated: May 26, 2016
Status: Resolved
Products Affected - Description
-
- Azithromycin intravenous lyophilized powder for solution for injection, Pfizer, 500 mg, ADD-Vantage vial, 10 count, NDC 00409-0144-11
- Azithromycin intravenous lyophilized powder for solution for injection, Sagent, 500 mg, vial, 10 count, NDC 25021-0112-10
Reason for the Shortage
-
- Fresenius Kabi had azithromycin on shortage due to increased demand.
- Hospira has azithromycin injection on shortage due to manufacturing delays.
- Sagent has azithromycin injection on shortage due to manufacturing delays.
Available Products
-
- Zithromax intravenous lyophilized powder for solution for injection, Pfizer, 500 mg, vial, 10 count, NDC 00069-3150-83
- Azithromycin intravenous lyophilized powder for solution for injection, Apotex, 500 mg, vial, 10 count, NDC 60505-6076-04
- Azithromycin intravenous lyophilized powder for solution for injection, Fresenius Kabi, 500 mg, vial, 10 count, NDC 63323-0398-10
Estimated Resupply Dates
-
- Hospira has azithromycin injection on back order and the company estimates a release date of July 2015.
- Sagent has azithromycin injection on back order and the company estimates a release date of July 2015.
Updated
Updated May 26, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 2, 2013 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.